Do you have some examples? And an estimate of how this affects the overall cost in drugs?
We’re talking about RE Importation. Not just buying drugs from foreign suppliers.
Drug companies are engaging in price discrimination - i.e. charging what the market will bear. Obviously, the market price for a drug in a wealthy country like the U.S. is going to be different than the market price for a drug in the Congo or in Argentina. Because the marginal cost of production is low, drug manufacturers can sell drugs at the profit-maximizing price in each country.
But if you allow cheap drugs from the Congo to be re-imported into the U.S., it will eat into U.S. profits. The result is that the drug company will have to set one price for both countries - which will price the drug out of the market in the poorest countries. This will hurt drug company profits, which could easily mean they’ll have to charge higher overall prices (or at best the U.S. price won’t come down if it’s set at the market price - they’ll just destroy the drug markets in other countries).
All you’ll be doing is hurting poor people in Africa and elsewhere in your never-ending quest to take away ‘excess profits’ from the evil drug companies. And if you make the global market overall lesss profitable because you’ve destroyed the efficient price setting mechanism of discrimination, you’ll make it harder to raise R&D capital.
If you want to reduce the cost of drugs, you might want to look at the problem of a 10-15 year FDA approval process that costs over a billion dollars, which has to be recouped over a 20-year patent lifetime. That’s what’s controlling the price of drugs - that and the fact that drugs are becoming increasingly sophisticated and expensive to create.
Again, this isn’t a given. The end result could simply be that drug companies will raise their international prices to match American prices. Or, they could raise them enough so that they’re still slightly cheaper, but not enough to make it worthwhile to re-import. If American drugs represent the bulk of their profits, eliminating re-importation will simply destroy foreign markets - especially in the poorest countries where the differential is greatest. Why do you hate poor African children? Is getting a 5% price cut in your drugs worth having the drug companies essentially stop selling needed drugs to poor people? That could easily be the result.